BusinessActinium Pharmaceuticals Strengthens Targeted Myeloablation Focused Clinical Development Team with New Hires Including Experienced Bone Marrow Transplant Physician and Drug Developer Vijay Reddy, M.D., Ph.D. as Vice President, Clinical DevelopmentBy Nasdaq OMXApr 18, 2018, 11:30 AM UTC
BusinessActinium Pharmaceuticals to Present at 30th Annual ROTH ConferenceBy Nasdaq OMXMar 7, 2018, 12:30 PM UTC
